|Assessment Status||Rapid Review Complete|
|Indication||For acute, postoperative pain management in adults. Readyfusor is used to maintain a continuous peripheral nerve block (CPNB) via a continuous infusion.|
|Rapid review commissioned||09/11/2018|
|Rapid review completed||13/12/2018|
|Rapid review outcome||A full HTA is not recommended. The NCPE recommends that Ropivicaine Readyfusor not be considered for reimbursement at the submitted price.|
This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.